In addition, high-risk group had significantly elevated levels in glycolysis and recognition of tumor cells, but lower levels in IFNg response, inhibitor cells (Tregs), innate immunity, priming and activation of immunology and T cells (Fig. 9F, G). The gene discussed is IFNG; the disease is neoplasm.